(Applicant's Description) The San Antonio Cancer Institute (SACI) represents the combined cancer research programs of a private, not-for-profit institution, the Cancer Therapy and Research Center (CTRC), and a state-supported academic medical center, The University of Texas Health Science Center at San Antonio (UTHSCSA). The collaborations fostered by this Institute integrate the outpatient cancer services and the clinical and preclinical research supported by the CTRC with the cancer-related scientific and academic programs of the UTHSCSA. Charles A. Coltman, JR., M,D,M has served as the Director of the San Antonio Cancer Institute since its inception in 1990. The six research programs presented in this application encompass the major research activities of the San Antonio Cancer Institute: Breast Cancer, Cancer Prevention and Health Promotion, DNA repair and Tumor Suppressor Genes, Experimental Therapeutics, Growth Factor, and Molecular Genetics. Members of the Institute are also provided with access to fourteen Shared Resources that provide technology and expertise to enhance research productivity and scientific collaborations within the Institute: Antigen and Antibody Production, Biostatistics and Data Processing, Cell and Tissue Bioprocessing, Clinical Investigations, Common Equipment Maintenance, Genetics Resources, Flow Cytometer Laboratory, High Throughput Screening Technology, Laboratory Animal Resources, Nucleic Acids Technology, Pathology, Pharmacology, Protein/Peptide Resource, and Transgenic Mouse Resource. At the present time, the Institute includes the activities of 161 members, or almost double the size of the membership at the time of the initial core grant application. Many of these members have concentrated their efforts in basic science research that enhances the Institute's goal of increasing its translational research activities. Even more indicative of the Institute's growth is the fact that, at the end of 1996, cancer center members were supported by approximately $36 million annually in grants and contracts, an increase of 200 percent since 1990. The San Antonio Cancer Institute, through collaborations with its affiliated clinical facilities, CTRC and UTHSCSA of community outreach and cancer prevention and education efforts in San Antonio and throughout South Texas.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA054174-09S1
Application #
2849504
Study Section
Special Emphasis Panel (ZCA1-SRRB-3 (J1))
Program Officer
Shafik, Hasnaa
Project Start
1994-08-19
Project End
2002-07-31
Budget Start
1999-08-01
Budget End
2000-07-31
Support Year
9
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Cancer Therapy and Research Center
Department
Type
DUNS #
010550366
City
San Antonio
State
TX
Country
United States
Zip Code
78229
Chalela, Patricia; Muñoz, Edgar; Gallion, Kipling J et al. (2018) Empowering Latina breast cancer patients to make informed decisions about clinical trials: a pilot study. Transl Behav Med 8:439-449
Chalela, P; Munoz, E; Inupakutika, D et al. (2018) Improving adherence to endocrine hormonal therapy among breast cancer patients: Study protocol for a randomized controlled trial. Contemp Clin Trials Commun 12:109-115
Weiner, Marc; Gelfond, Jon; Johnson-Pais, Teresa L et al. (2018) Elevated Plasma Moxifloxacin Concentrations and SLCO1B1 g.-11187G>A Polymorphism in Adults with Pulmonary Tuberculosis. Antimicrob Agents Chemother 62:
Liu, Jinyou; Sareddy, Gangadhara R; Zhou, Mei et al. (2018) Differential Effects of Estrogen Receptor ? Isoforms on Glioblastoma Progression. Cancer Res 78:3176-3189
Chakravarthy, Divya; Muñoz, Amanda R; Su, Angel et al. (2018) Palmatine suppresses glutamine-mediated interaction between pancreatic cancer and stellate cells through simultaneous inhibition of survivin and COL1A1. Cancer Lett 419:103-115
Van Skike, Candice E; Jahrling, Jordan B; Olson, Angela B et al. (2018) Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer's disease and vascular cognitive impairment. Am J Physiol Heart Circ Physiol 314:H693-H703
Cooney, Jeffrey D; Lin, An-Ping; Jiang, Daifeng et al. (2018) Synergistic Targeting of the Regulatory and Catalytic Subunits of PI3K? in Mature B-cell Malignancies. Clin Cancer Res 24:1103-1113
Zhu, Haiyan; Gu, Xiang; Xia, Lu et al. (2018) A Novel TGF? Trap Blocks Chemotherapeutics-Induced TGF?1 Signaling and Enhances Their Anticancer Activity in Gynecologic Cancers. Clin Cancer Res 24:2780-2793
Bandyopadhyay, Abhik; Favours, Edward; Phelps, Doris A et al. (2018) Evaluation of patritumab with or without erlotinib in combination with standard cytotoxic agents against pediatric sarcoma xenograft models. Pediatr Blood Cancer 65:
Azpurua, Jorge; Mahoney, Rebekah E; Eaton, Benjamin A (2018) Transcriptomics of aged Drosophila motor neurons reveals a matrix metalloproteinase that impairs motor function. Aging Cell 17:

Showing the most recent 10 out of 989 publications